Biolase marks 12 US, international patents in 12 months

Dental laser and medical device company Biolase has received five new patents in the U.S. and seven foreign patents in the past 12 months. 

Advertisement

Biolase has the largest portfolio in the industry, with 302 issued patents and 31 pending applications, according to a July 25 news release. 

President and CEO John Beaver said the new patents are all related to the Biolase Waterlase system and Epic diode technologies.

At the Becker's 5th Annual Future of Dentistry Roundtable, taking place November 12–14 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.